Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
- NEW YORK -- ImClone Systems Incorporated (NASDAQ: IMCL) today announced that it has signed settlement and sublicensing agreements with the Massachusetts Institute of Technology MIT and Repligen Corporation to end litigation related to U.S. Patent No. 4,663,281, which is owned by MIT and exclusively licensed to Repligen. All terms of...
- Research articles 2007-09-10
- Defence rests in Martha Stewart case
- NEW YORK AFP ? Martha Stewart's defence team rested after calling a sole witness in the high-profile securities fraud case involving the multi-millionaire American lifestyle guru. Stewart herself did not take the witness stand, with her lawyers seemingly keen to indicate to the jury that federal prosecutors had failed...
- Research articles 2004-02-25
- New plan to keep biotech firms from talking out of school: FDA will watch what companies say during pre-market review process
- The Food and Drug Administration and the Securities and Exchange Commission have adopted a new plan to ensure public biotechnology companies tell their investors the truth about their dealings with the FDA. The initiative, first unveiled Feb. 5, calls for FDA employees to report companies that spread false and...
- Research articles 2004-02-16
- Prosecution rests in Martha Stewart case
- NEW YORK AFP ? The prosecution rested in the high-profile securities fraud case involving multi-millionaire American lifestyle guru Martha Stewart. After almost four weeks of testimony from some 20 witnesses, Stewart's lawyers will now get their turn to defend their client, accused of acting on an improper tip when...
- Research articles 2004-02-20
- Jurors hear taped inquiry of Stewart's former broker
- NEW YORK -- Jurors in the trial of Martha Stewart finally heard the voice of Stewart's co-defendant Wednesday, when prosecutors played a recording of testimony that Stewart's former broker, Peter Bacanovic, gave to the Securities and Exchange Commission two years ago. Bacanovic told SEC investigators in February 2002 that...
- Research articles 2004-02-12
- Stewart's assistant breaks down during testimony
- NEW YORK -- Martha Stewart's personal assistant broke down in tears on the witness stand Monday as a prosecutor zeroed in on the events of Dec. 27, 2001, the day Stewart made her controversial sale of ImClone stock. Ann Armstrong, Stewart's personal assistant since 1998, had already told the...
- Research articles 2004-02-10
- Government to Work to Stop Distribution of Bad Information from Biotech Firms.
- By Terri Somers, The San Diego Union-Tribune Knight Ridder/Tribune Business News Feb. 5--The Securities and Exchange Commission and the Food and Drug Administration will unveil a plan today to work together to crack down on the dissemination of false and misleading information...
- Research articles 2004-02-05
- Former Broker's Assistant Testifies that Stewart Used Insider Stock Tip.
- By Greg B. Smith, Daily News, New York Knight Ridder/Tribune Business News Feb. 5--The star witness in the Martha Stewart trial lived up to his billing yesterday, testifying that the domestic diva used an illegal insider stock tip to sell off all...
- Research articles 2004-02-05
- Broker says Martha Stewart sold stock after inside tip
- NEW YORK AFP ? The star witness against lifestyle guru Martha Stewart admitted he gave her an illegal tip before she dumped her holding in biotech firm ImClone. Former Merrill Lynch broker's assistant Douglas Faneuil delivered the most damaging testimony yet against Stewart. The high-profile businesswoman is accused...
- Research articles 2004-02-04
- Faneuil describes ImClone stock sales
- NEW YORK -- After almost a full week of testimony in the trial of Martha Stewart, government prosecutors finally produced a witness who testified to direct involvement in a crime allegedly committed by her Merrill Lynch broker, Peter Bacanovic. Douglas Faneuil, Bacanovic's former assistant, took the stand Tuesday afternoon,...
- Research articles 2004-02-04
- Trial begins for US homemaking icon Martha Stewart
- NEW YORK AFP ? American lifestyle entrepreneur Martha Stewart arrived in federal court as the final phase of jury selection got underway for her trial on charges of securities fraud and obstruction of justice. Stewart, 62, looked grim as she walked through a phalanx of photographers into the Manhattan...
- Research articles 2004-01-20
- Charges against Martha Stewart Are Unusual, Not Unprecedented.
- By Greg B. Smith, Daily News, New York Knight Ridder/Tribune Business News Jun. 15--Two days before Martha Stewart was charged with lying to the feds about her sale of ImClone stock, regulators quietly nailed another executive for ImClone insider trading. ...
- Research articles 2003-06-15
- ImClone's Founder Is Sentenced to Prison Just as Cancer Drug Nears Approval.
- By Randi F. Marshall, Newsday, Melville, N.Y. Knight Ridder/Tribune Business News Jun. 11--Nearly 20 years ago, brothers Samuel and Harlan Waksal founded a small biotechnology company with the dream of finding a miracle cancer drug. Now that a potentially effective...
- Research articles 2003-06-11
- Martha Stewart Resigns as Chairwoman, Chief Executive of Firm after Indictment.
- By Greg B. Smith, Daily News, New York Knight Ridder/Tribune Business News Jun. 5--Martha Stewart is under indictment and out of a job. Hours after she pleaded not guilty yesterday to a nine-count federal indictment, her company announced Stewart's resignation as...
- Research articles 2003-06-05
- Stocks Are Still on Roar.
- By Eric Herman, Daily News, New York Knight Ridder/Tribune Business News May 31--Stocks continued to rocket higher yesterday, propelled by reports of improved consumer confidence and manufacturing, bringing the markets to their third straight month of gains. The Dow...
- Research articles 2003-05-31
- Daily News, New York, Ticker Column.
- Daily News, New York Knight Ridder/Tribune Business News Apr. 11--IMCLONE MAY BE CUT BY NASDAQ: Nasdaq halted trading of ImClone shares for over an hour yesterday after the troubled biotech company delayed filing its 2002 annual report. Nasdaq regulators also...
- Research articles 2003-04-11
- Look Who's Talking
- He might have been just a $50,000-a-year assistant at Merrill Lynch. But dress him in a coral-pink silk shirt and royal-blue blazer by Fendi, and in the pages of W magazine he's "Banker Douglas Faneuil," curly-haired and baby-faced with the blush of hipness on his cheeks. Faneuil, 26, has improbably...
- Research articles 2002-10-07
- More Head Wind for Martha
- Even when Martha Stewart cooperates with the insider-trading probe that's dogged her all summer, she still manages to appear less than forthcoming. Last week her lawyers delivered more than 1,000 pages of e-mails, phone records and other documents to congressional investigators demanding the domestic diva clear up discrepancies in her...
- Research articles 2002-09-02
- Goodyear outlook better than expected
- AKRON, Ohio AP -- Goodyear said on Wednesday that earnings for the second quarter will be better than expected because of cost cutting and improved sales from international operations. The world's largest tire company said it now expects to earn 10 cents to 15 cents a share...
- Research articles 2002-06-20
- More biotech deal-making ahead? (Pharmaceuticals & Fine Chemicals: M&A).(Brief Article)
- The recent acquisition of biotechnology firms by Johnson & Johnson and Schering may be the beginning of a surge in pharmaceutical M&A in the biotechnology sector, according to a report from Goldman Sachs (CW, Mar. 27, pp. 7, 25). The impetus is the need among pharmaceutical...
- Research articles 2002-04-03
- << Previous
- page 1 of 2
- Next >>
Content Types
Refining Tags
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
